Brief: Kyowa Kirin Announces Discontinuation Of Rocatinlimab Clinical Trials
03/03/2026 13:07
March 3 (Reuters) - Kyowa Kirin Co Ltd 4151.T: KYOWA KIRIN ANNOUNCES DISCONTINUATION OF ROCATINLIMAB CLINICAL TRIALS Source text: ID:nGNX1Pcm15 Further company coverage: 4151.T ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kyowa Kirin
See all newsFactbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Brief: Kyowa Kirin Announces Agreement With US Administration To Reduce Treatment Costs For Americans
Table: Kyowa Kirin 6-MTH group results (IFRS)
Brief: Kyowa Kirin Says European Commission Approves Crysvita For Infants With X-Linked Hypophosphataemia